在诊断心力衰竭时使用尿素和心声回声学
Khawaja M Talha1, James L Januzzi2, Tong Meng3
1Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
European journal of heart failure
|February 21, 2024
概括
在美国,使用心声学和尿素 (NP) 的心力衰竭 (HF) 诊断测试仍然很低. 越来越多的住院诊断表明,早期HF治疗和改善患者治疗结果的机会被错过了.
科学领域:
- 心脏病学 心脏病学
- 诊断成像 诊断成像 诊断成像
- 生物标志物 生物标志物
背景情况:
- 国际指导方针主张在心力衰竭 (HF) 诊断中进行心声回声和尿酸 (NP) 测试.
- 这些关键诊断工具在美国的现实世界使用情况尚未得到充分记录.
研究的目的:
- 评估美国使用心声回声和NP测试诊断HF的当代趋势.
- 为了确定诊断测试使用的模式,相对于住院患者和门诊患者的设置.
主要方法:
- 分析TrinetX数据库对美国 (2016-2019年) 成年HF诊断的分析.
- 在HF诊断后一年内评估心声学和NP测试率.
- 使用Cochran-Armitage趋势测试对时间趋势的评估.
主要成果:
- 在124,126名患者中,57%接受了心声回声测试,55%接受了NP测试;25%没有任何测试.
- 观察到对住院HF诊断的显著趋势 (p < 0.001).
- 对于住院患者的诊断,两种测试的使用率都在增加,但整体率仍然低于最佳水平.
结论:
- 在被诊断为HF的患者中,观察到推的心声回声和NP测试的低率.
- 住院HF诊断的增加表明诊断和治疗启动的潜在延迟.
- 优化这些诊断测试的使用可能会导致更早的干预和更好的HF患者结果.
相关概念视频
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Imaging Studies for Cardiovascular System I:Echocardiography
331
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
331
Imaging Studies for Cardiovascular System II:Types of Echocardiography
271
Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
271
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
92
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92


